Linked Life Data

16889857

Source:http://linkedlifedata.com/resource/pubmed/id/16889857

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-4-6
pubmed:abstractText
Efficacy of cellular cardiomyoplasty seems to occur in a dose-related manner. However, the safety of multiple transendomyocardial transplantation procedures to administer high cell dosages has not been previously reported. The aims of this study were to assess the short- and intermediate-term results of a repeated cell administration strategy and evaluate the safety of an "off-the-shelf" allogeneic mesenchymal stem cell (MSC) source.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1874-1754
pubmed:author
pubmed:issnType
Electronic
pubmed:day
2
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
360-4
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, "off-the-shelf", cellular cardiomyoplasty strategy.
pubmed:affiliation
Caritas St Elizabeth's Medical Center and Tufts University School of Medicine, Boston, MA, United States. doctorpoh@yahoo.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't